Bacil Pharma Schedules Board Meeting for Q2 FY27 Financial Results
Bacil Pharma Ltd 路 Intimation 路 14 Oct 2026, 5:30 am
Bacil Pharma Schedules Board Meeting for Q2 FY27 Financial Results Bacil Pharma Limited has informed BSE that a meeting of its Board of Directors is scheduled for 14th Oct'26. The board will primarily consider and approve the unaudited financial results of the company for the quarter and half-year ended 30th Sep'26, alongside addressing any other business matters permitted by the Chairperson.
Original exchange filing (PDF)
More announcements from Bacil Pharma Ltd
- Intimation regarding execution of Agreement by Wholly Owned Subsidiary of the Company 路 05 Nov 2026
- Un-Audited Financial Results for the Quarter and Half Yearly Ended 30th September, 2026 路 14 Oct 2026
- Outcome of Board Meeting held on 14th October, 2026 路 14 Oct 2026
- Intimation for resignation of Company Secretary 路 09 Oct 2026
- Scrutinizers Report for the Annual General Meeting of the Company for FY 2025-2026 路 24 Sept 2026
- Outcome/Proceeding of Annual General Meeting of the Company 路 23 Sept 2026
- Annual Report for the Financial Year 2025-2026 路 31 Aug 2026
- Notice of Annual General Meeting to be held on 23rd September, 2026 路 30 Aug 2026
